Fully covered self-expanding metallic stent placement for benign refractory esophageal strictures

Kahalekar, Vinit; Gupta, Deepak Trilokinath; Bhatt, Pratin; Shukla, Akash; Bhatia, Shobna

doi:10.1007/s12664-017-0764-2

Cited by 4 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…5,10 Although the most common incidental diseases after esophageal stent placement include bleeding, perforation, migration, pain, and obstruction, a false aneurysm may also occur. [10][11][12][13] A pseudoaneurysm is a pulsating hematoma which develops when the fibers around the tissue are wrapped into masses that communicates with the arterial lumen after the rupture of the artery wall. A false aneurysm is deficient in 3 layers of the arterial wall in contrast to a true aneurysm.…”

Section: Discussionmentioning

confidence: 99%

A Pseudoaneurysm of Aberrant Right Subclavian Artery Caused by Esophageal Stent Placement Because of Esophageal Stricture After Endoscopic Submucosal Dissection

Shi

Wang

Chen

et al. 2019

Surgical Laparoscopy, Endoscopy &Amp; Percutaneous Techniques

View full text Add to dashboard Cite

A 67-year-old man who received endoscopic submucosal dissection for an early squamous esophageal cancer was hospitalized for dysphagia. The mucosal defect was over three quarters of the circumference, and the distal edge of the resection scar formed the stenosis after 8 months. After experiencing conservative treatment, probe expansion, and esophageal stent placement, the symptom of deglutition disorder in the patient was improved, but persistent hemorrhage and progressive anemia occurred in the short term. An enhanced neck and chest computed tomography (CT) showed a contrast agent leaked from the aberrant right subclavian artery to the esophagus. A pseudoaneurysm of the aberrant right subclavian artery and subclavian artery-esophageal fistula were diagnosed by CT angiography. Although false aneurysms developing after iatrogenic injury and trauma have been reported, those caused by esophageal stent placement because of esophageal stricture after endoscopic submucosal dissection have not. When persistent hemorrhage and progressive anemia develop after esophageal stent placement, an enhanced CT should be performed to exclude the false aneurysm.

show abstract

Section: Discussionmentioning

confidence: 99%

A Pseudoaneurysm of Aberrant Right Subclavian Artery Caused by Esophageal Stent Placement Because of Esophageal Stricture After Endoscopic Submucosal Dissection

Shi

Wang

Chen

et al. 2019

Surgical Laparoscopy, Endoscopy &Amp; Percutaneous Techniques

View full text Add to dashboard Cite

show abstract

“…Tumor cells can take up human serum albumin through endocytosis; therefore, albumin-based nanoparticles can show high stability without cytotoxicity [32]. Metallic nanometer-sized particles, such as silver, gold, and magnetic metals show the property of the enhanced surface to volume ratio; therefore, they have good applications in oligonucleotide delivery [33].…”

Section: Drug Delivery Systems Of Nucleic Acid Drugsmentioning

confidence: 99%

Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment

Yamakawa

Nakano‐Narusawa

Hashimoto

et al. 2019

IJMS

View full text Add to dashboard Cite

Approximately 30% of pancreatic cancer patients harbor targetable mutations. However, there has been no therapy targeting these molecules clinically. Nucleic acid medicines show high specificity and can target RNAs. Nucleic acid medicine is expected to be the next-generation treatment next to small molecules and antibodies. There are several kinds of nucleic acid drugs, including antisense oligonucleotides, small interfering RNAs, microRNAs, aptamers, decoys, and CpG oligodeoxynucleotides. In this review, we provide an update on current research of nucleic acid-based therapies. Despite the challenging obstacles, we hope that nucleic acid drugs will have a significant impact on the treatment of pancreatic cancer. The combination of genetic diagnosis using next generation sequencing and targeted therapy may provide effective precision medicine for pancreatic cancer patients.

show abstract

Changing epidemiology of esophageal stent placement for dysphagia: a decade of trends and the impact of benign indications

Chan

Balasubramanian

Modi

et al. 2020

Gastrointestinal Endoscopy

View full text Add to dashboard Cite

Fully covered self-expanding metallic stent placement for benign refractory esophageal strictures

Abstract: Fully covered SEMS is safe and effective for refractory benign non-corrosive esophageal strictures.

Cited by 4 publications

References 18 publications

A Pseudoaneurysm of Aberrant Right Subclavian Artery Caused by Esophageal Stent Placement Because of Esophageal Stricture After Endoscopic Submucosal Dissection

A Pseudoaneurysm of Aberrant Right Subclavian Artery Caused by Esophageal Stent Placement Because of Esophageal Stricture After Endoscopic Submucosal Dissection

Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment

Changing epidemiology of esophageal stent placement for dysphagia: a decade of trends and the impact of benign indications

Contact Info

Product

Resources

About